This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Endo International plc
Endo International plc, commonly referred to as Endo, is a global healthcare company headquartered in Ireland (IE). Founded in 1997, Endo has established itself as a key player in the pharmaceutical industry, focusing on pain management, urology, and other therapeutic areas. The company operates primarily in North America, Europe, and Asia, delivering innovative solutions to improve patient outcomes. Endo's core products include a range of branded and generic medications, with a strong emphasis on specialty pharmaceuticals. Notable achievements include the development of unique formulations that enhance drug delivery and efficacy. With a commitment to quality and patient care, Endo International plc continues to strengthen its market position, contributing significantly to advancements in healthcare.
DitchCarbon Score
How does Endo International plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Endo International plc's score of 28 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Endo International plc, headquartered in Ireland (IE), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Endo Inc., which may influence its climate commitments and reporting practices. As of now, Endo International plc has not established any documented reduction targets or climate pledges. This lack of specific initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the absence of direct emissions data and reduction commitments, it is essential to monitor future disclosures from Endo International plc and its parent company, Endo Inc., for any updates on their climate initiatives and emissions performance.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 27,475,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 37,395,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Endo International plc is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
